Quadcap Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Buy
+1,095
New +$213K 0.02% 365
2025
Q4
Sell
-1,095
Closed -$209K 404
2025
Q3
$209K Sell
1,095
-57
-5% -$10.1K 0.02% 378
2025
Q2
$207K Buy
+1,152
New +$200K 0.03% 368

Other funds holding DGX

Quadcap Wealth Management's DGX Position: Q1 2026 in Review

Quadcap Wealth Management opened a new position in Quest Diagnostics (DGX) in Q1 2026: 1,095 shares worth $215K. The stake represents 0.02% of the portfolio and ranks #365 among its holdings. This is a return to the name: Quadcap Wealth Management previously reported a position in DGX as recently as Q3 2025.

Quadcap Wealth Management first reported a position in DGX in Q2 2025 and has held it in 3 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Quadcap Wealth Management held 1,095 shares of Quest Diagnostics worth $215K as of Q1 2026.
  • Quest Diagnostics was a new Quadcap Wealth Management position in Q1 2026.
  • Quest Diagnostics made up 0.02% of Quadcap Wealth Management's portfolio in Q1 2026, its #365 holding.
  • Quadcap Wealth Management first reported a position in Quest Diagnostics in Q2 2025 and has held it in 3 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.